Future could include gene therapy, MMP regulators and inhibitors, PDT
Feb 15, 2007
By:Ed Edelson
New York—Some antifibrosis drugs and techniques on the horizon appear promising, but more data, especially from controlled human trials, are needed, Paul J. Lama, MD, told those attending the Glaucoma 2006 meeting here.
 |
Treatment guidelines still needed, however; approach does not work for everyone
Feb 1, 2007
By:Ed Edelson
New York—The idea of using selective laser trabeculoplasty (SLT) for steroid-induced glaucoma originated with a patient's stubborn resistance to surgery, according to Janet P. Serle, MD.
|
Patients had lower IOP, took fewer medications over long term than those with phaco alone
Jan 15, 2007
By:Ed Edelson
New York—In a controlled trial, endocyclophotocoagulation (ECP) combined with phacoemulsification showed significant benefits in treating cataract patients who also have glaucoma, according to Stanley J. Berke, MD.
|
Pressure tends to peak just before waking, glaucoma specialist explains
Dec 15, 2006
By:Ed Edelson, Robert N. Weinreb, MD
New York —"Measurement of IOP in 2006 is under pressure," Robert N. Weinreb, MD, told the Glaucoma 2006 meeting attendees here. "We need to reassess both the quality and the quantity of our IOP measurements.
|
Nov 1, 2006
By:Ed Edelson, Jayakrishna Ambati, MD
Lexington, KY—Animal studies point to two components of drusen as the driving force for the neovascularization that causes age-related macular degeneration (AMD) —a discovery that opens the way to early detection and drug therapy to prevent the condition, said Jayakrishna Ambati, MD.
|
Fundamental characteristics include neural rim, optic disc, scleral ring factors
Oct 15, 2006
By:Ed Edelson, David S. Greenfield, MD
New York—It is essential for clinicians who treat glaucoma to recognize all the fundamental characteristics of the glaucomatous nerve, David S. Greenfield, MD, said at the Glaucoma 2006 meeting here.
|
However, glaucoma progression is not so easy to detect with these instruments
Oct 1, 2006
By:Ed Edelson, Christopher A. Girkin, MD, MSPH
New York—Some imaging devices may help predict which patients will develop glaucoma, but "they will not supplant clinical assessment of the optic disc by a trained observer," said Christopher A. Girkin, MD, MSPH, to attendees of the Glaucoma 2006 meeting here.
|
Oct 1, 2006
By:Ed Edelson, Robert Ritch, MD
New York—A patient with exfoliation syndrome (XFS) may have the worst type of open-angle glaucoma, according to Robert Ritch, MD, who opened a session on XFS at the Glaucoma 2006 meeting.
|
European trials produced good results with sustained IOP reduction at 24 months
Sep 1, 2006
By:Ed Edelson
New York—A gold micro-shunt (GMS, SOLX) implant holds promise for reducing complications of trabeculectomy by lowering IOP, said Celso Tello, MD.
|
| 
Practice Tools
